Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Vascular resistance is a physiological concept referring to the opposition that blood encounters as it flows through vessels[1][7][10]. It is a mathematical function of vessel radius (most important), blood viscosity, and vessel length, with radius having a fourth-power effect—small changes in vessel diameter (via vasodilation or vasoconstriction) markedly affect resistance[8][10]. Clinically, terms such as systemic vascular resistance (SVR) and pulmonary vascular resistance (PVR) specify this phenomenon within systemic or pulmonary circulations[7]. Although critical for diagnosis and management of cardiovascular conditions (especially hypertension and heart failure), vascular resistance itself is not a molecular target but is modulated by drugs acting on underlying cellular proteins (such as ion channels, receptors, or enzymes on smooth muscle cells)[1][4][7].
Vasodilation (drugs act on smooth muscle to increase vessel diameter, reducing resistance); Modulation of blood viscosity; Neurohormonal blockade (renin-angiotensin system, endothelin pathway)
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vascular resistance.